BMEZ Valuation

BlackRock Health Sciences Term Trust (BMEZ) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of --. The fair price of BlackRock Health Sciences Term Trust (BMEZ) is between -- to -- according to relative valuation method.

BMEZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of BlackRock Health Sciences Term Trust (BMEZ) is between -- to -- according to relative valuation method.

The average P/S ratio for BMEZ's competitors is 0.00, providing a benchmark for relative valuation. BlackRock Health Sciences Term Trust Corp (BMEZ) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

As of Mar 02 2026, BlackRock Health Sciences Term Trust (BMEZ) has a P/B ratio of NaN. This indicates that the market values BMEZ at NaN times its book value.

As of Mar 02 2026, BlackRock Health Sciences Term Trust (BMEZ) has a FCF Yield of NaN%. This means that for every dollar of BlackRock Health Sciences Term Trust's market capitalization, the company generates NaN cents in free cash flow.

As of Mar 02 2026, BlackRock Health Sciences Term Trust (BMEZ) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of BlackRock Health Sciences Term Trust's expected earnings over the next 12 months.

As of Mar 02 2026, BlackRock Health Sciences Term Trust (BMEZ) has a Forward P/S ratio of NaN. This means the market is valuing BMEZ at $NaN for every dollar of expected revenue over the next 12 months.